Dra. Elena Arrondo. License Number:

Similar documents
2 ND TRENDS IN GLAUCOMA

PROGRAMME GLAU COMA 3RDTRENDS IN. International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery. 9 th & 10 th November

CURRICULUM VITAE. Marcos Muñoz M.D.

Elena Núñez. Vision Therapy Area.

Dr. Óscar Gris. License Number: 28,186

Dr. Rafael Navarro. License Number:

2nd Trends in Glaucoma

Dra. Luz María Vásquez

Preliminary Programme

Preliminary Programme

NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY EDUCATIONAL OBJECTIVES AND GOALS

Preliminary Scientific Program Update February 24, 2014

FINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona

SCIENTIFIC PROGRAM. Pediatric ophthalmology- Optometry challenges (max 20 attendees)

WGA. The Global Glaucoma Network

Review of the Ahmed versus Baerveldt study 5-year treatment outcomes

19th ESCRS Winter Meeting

MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND PACHYMETRY. POLICY NUMBER: CATEGORY: Technology Assessment

Dr. Rafael Navarro. License Number:

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing

Preliminary Program 2019

Champlain LHIN. Estimated that 55,563 people over age 18 live with diabetes

Management of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

Curriculum Vitae (CV)

THE CHRONIC GLAUCOMAS

Clinical Commissioning Policy Proposition: Keratoprosthesis for corneal blindness

COMMITMENT TO MEDICAL EXCELLENCE

REFRACTIVE SURGERY COMPLICATION MANAGEMENT AND WHAT S NEW IN OCULAR SURFACE FRIDAY APRIL 5 TH

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar

Corporate Medical Policy

Routine OCT and UBM of the anterior segment

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

Curriculum Vitae (Jan 2015)

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110

Aqueous Shunts and Stents for Glaucoma

Curriculum Vita Date updated: November 4th, 2013

Innovations in Glaucoma Drug Delivery What the Future Holds. Justin Schweitzer, OD, FAAO Vance Thompson Vision Sioux Falls, South Dakota

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma)

Hong Kong College of Surgical Nursing

Peretyagin O.A., Cand. Med. Sc., Ass. Prof.; Dmitriev S.K., Dr. Med. Sc., Prof.; Lazar Yu.M., Cand. Med. Sc.; Tatarina Yu.A., Junior Research Fellow

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

Department of Ophthalmology

Aqueous Shunts for the Treatment of Glaucoma

Micro-Invasive Glaucoma Surgery (Aqueous Stents)

Anterior Segment Optical Coherence Tomography for the Quantitative Evaluation of the Anterior Segment Following Boston Keratoprosthesis

Dr. D. Y. Patil Medical College, Pimpri, Pune

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

Managing & Avoiding Post-Op Complications in Tube Surgeries

Dr. Daniel Elies. License Number:

CLASS-y Laser Treats Glaucoma

Corporate Medical Policy

750,00 HRK 500,00 HRK 4, HRK 3.000,00 HRK 5, HRK 3.500,00 HRK 6, HRK 4.000,00 HRK 6, HRK 5.000,00 HRK

Phase II (Year 2 & 3) At the completion of this phase, trainees possess:

53 year old woman attends your practice for routine exam. She has no past medical history or family history of note.

Syllabus-Ophthalmology Rotation Course: Objectives & Goals LOYOLA UNIVERSITY CHICAGO STRITCH SCHOOL OF MEDICINE

CATARACT AND GLAUCOMA SURGEON CORNEA AND LASIK SPECIALIST

Department of Ophthalmology

Eye and Ocular Adnexa, Auditory Systems

Corporate Medical Policy

9/25/2017 CASE. 67 years old On 2 topical meds since 3 years. Rx: +3.0 RE LE

SUPPLEMENTARY INFORMATION

Corporate Medical Policy

Collaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012

The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3%

Glaucoma research at Moorfields

Optometry Student Extern Manual. Miami VA Medical Center

EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA

Location: UCLA STUDENT EXPERIENCES INPATIENT: OUTPATIENT: 10% 90% CONSULTATION: PRIMARY CARE: 40% 60% TYPICAL WEEKLY SCHEDULE

Elements for a public summary. Overview of disease epidemiology

GENERAL INFORMATION GLAUCOMA GLAUCOMA

Dr. Harvey Richman, OD, FAAO, FCOVD Diplomate American Board of Optometry Executive Committee AOA Third Party Center Founder Ask the AOA Coding

FUCH S DYSTROPHY & CATARACT SURGERY TREATMENT ALGORITHM

DNB QUESTIONS 2014 PAPER 1. b) What are the Clinical Conditions in Which Nystagmus is Seen? c) Management of Nystagmus.

Targeting Intraocular Pressure in Glaucoma: a Teaching Case Report 1

PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS

Landmark Tube Trials

Understanding Angle Closure

The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado

UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Ophthalmology. Academic year 2016/2017. izv. prof. dr. sc. Smiljka Popović-Suić

Clinical Study Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in Branch Retinal Vein Occlusions

THE CURRENT TREATMENT OF GLAUCOMA IS DIrected


Question Papers of BHU

Revitalization of the Anterior Segment: Corneal Transplantation and Secondary Lens Repair

GENERAL INFORMATION MOSMAN CLINIC

GLAUCOMA SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES

Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study


TRABECULECTOMY THE BEST AND WORST CANDIDATES

Ophthalmology. Books Journals Electronic Resources. Visit to order these and other new and bestselling titles in Ophthalmology

UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Ophthalmology. Academic year 2018/2019. izv. prof. dr. sc. Smiljka Popović-Suić

What is the Value of Swept Source oct Technology in Biometry? Experts discussed the IOLMaster 700 at the ESCRS ebook. Content provided by:

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy.

Common Causes of Vision Loss

Issue 15 The following key clinical peer reviewed journals will be reviewed: MONTHLY RESEARCH UPDATE 151(3) American Journal of Ophthalmology 129(5)

Transcription:

Dra. Elena Arrondo The Glaucoma Department of the IMO, Institute of Ocular Microsurgery. Lecturer in the Glaucoma Master s Degree of the Institute of Ocular Microsurgery. License Number: 32.348 Curriculum Professional Profile She is a member of the Glaucoma Department of the IMO, Institute of Ocular Microsurgery, and Lecturer in the Glaucoma and Anterior Segment Master s Degrees of the IMO and the Faculty of Medicine of the Autonomous University of Barcelona. She specialises in glaucoma and the optic nerve, with a special interest in medical and surgical treatment of this disease. She has taken part in various multicenter clinical trials related to treatment of glaucoma. She has also collaborated as a Lecturer in Ocular Pathologies at the School of Optics of the Polytechnic University of Catalonia (2001-2003). Specialisation Glaucoma. Teaching She lectured in Ocular Pathology at the School of Optics and Optometry at the Polytechnic University of Catalonia between 2001 and 2003.

Research Principal researcher. DUOPROST. Phase III: Efficacy and safety assessment of fixed combination unpreserved Latanoprost eyedrops and Timolo 0.5% (T2347) versus Xalacom in ocular hypertensive or glaucomatous patients. (LT2347-PIII-12/13) Principal researcher. ARTEMIS. Efficacy and safety of bimatoprost sustained-release in patients with open-angle glaucoma or ocular hypertension. (192024-091) She has participated in several multi-centre clinical trials relating to the treatment of glaucoma. XALACO 912-OPT-0076-019: multi-centre safety study of Xalacom after five years in patients with primary open-angle glaucoma or ocular hypertension. Pfizer Ophthalmics. XALACO 0076-036: prospective, randomised, double-blind clinical trial of 3 months duration comparing the fixed combination of latanopost/timolol (Xalacom) administered at night with the use of the individual components separately (non-fixed combination) in patients with primary open-angle glaucoma or ocular hypertension. Pfizer Ophthalmics. Affiliations Member of the Catalonian Ophthalmology Society Member of the American Academy of Ophthalmology Other details of interest Member of the IMO Foundation Conferences and courses Arrondo E. (2016) 1) Organising committee. 2) Moderator. Session I: What do new technologies contribute to the diagnosis of glaucoma? 3) Speaker. Session VII. Glaucoma surgery II: Keratoprostheses and glaucoma. Session VIII Pros and Cons. Conjunctival blisters, yes or no: deep sclerectomy vs. canaloplasty. 2nd Trends in Glaucoma. Instituto de Microcirugía Ocular (IMO). Barcelona

Arrondo E. (2016) Speaker. Glaucoma and vitreoretinal surgery. 92nd Spanish Ophthalmology Society Conference. Malaga Arrondo E. (2016) Speaker. Instructional courses. Boston type 1 keratoprosthesis: from indications to innovations. ESCRS. Copenhagen Arrondo E. (2016) Speaker. Glaucoma drainage devices. Management of complications. 16th International Symposium on Controversial Issues in Glaucoma. Allergan. Madrid Arrondo E. (2016) Speaker. 3D Surgery: New surgical approaches. 25th Glaucoma Forum 21st Century. Santen. Barcelona Arrondo E. (2016) Live surgery. 7th edition Aurora 2016. Allergan. Instituto de Microcirugía Ocular (IMO). Barcelona Arrondo E. (2016) Glaucoma Workshop 2016. Baiona (Pontevedra) Arrondo E. (2016) 1) Speaker. Symposium video: Management of glaucoma secondary to possible iridocorneal endothelial syndrome and cataracts. 2) Moderator. Round table on inflammatory glaucoma. Interdisciplinary approach. 11th Spanish Glaucoma Society Conference. Toledo Arrondo E. (2016) Speaker. Course on the management of complex clinical glaucoma cases. Santa Creu i Sant Pau Hospital. Barcelona Arrondo E. (2016) 1) Speaker. Diagnosis of glaucoma through imaging. OCT in the diagnosis of myopic optic disc. 2) Speaker. Refractory glaucomas: treatment guidelines. Glaucoma secondary to vitreoretinal surgery. Intensive refresher course on the diagnosis and treatment of glaucoma. Instituto Barraquer. Barcelona Arrondo E. (2015) Speaker. Management of Glaucoma and Corneal Grafts. 13th Russian Glaucoma Society Meeting. Moscow Arrondo E. (2015) Video: Glaucoma associated with refractive surgery. 24th Glaucoma Forum. Santen. Barcelona Arrondo E. (2015) Speaker. How should we deal with postoperative hypertonia? 5th Glaucoma Course - Approach to secondary glaucomas. Valle Hebrón University Hospital. Barcelona Arrondo E. (2015) Moderator. Session II: Videos. 91st Spanish Ophthalmology Society Conference. Seville

Arrondo E. (2015) Moderator. Panel II: Glaucoma and Kpro, Management/prevention. Moderator: Future Perspective and Closing Comments. KPro Study Group Round Tables. Pre EuCornea. Instituto de Microcirugía Ocular. Barcelona Arrondo E. (2015) 6th Speaker. Management of glaucoma associated with corneal grafts. EuCornea Congress. Barcelona Arrondo E. (2015) Moderator. Free Paper Session: Glaucoma I ESCRS. Barcelona Arrondo E. (2015) Speaker. Instructional Courses: Boston type 1 keratoprosthesis: from indications to innovations. ESCRS. Barcelona Arrondo E. (2015) Speaker. Mini refresher symposium on the surgical management of glaucoma. Preoperative treatment. 15th International Symposium on Controversial Issues in Glaucoma. Madrid Arrondo E. (2015) 1) Speaker. Is BMU useful for learning about the dynamic anatomy of the anterior segment in angle-closure glaucoma? Does your therapeutic criterion change? 2) Speaker. Round table: The future of surgical treatment of glaucoma. 5th SIBAG Conference. Lisbon Arrondo E. (2015) Glaucoma Workshop 2015. La Toja (Pontevedra) Arrondo E. (2015) Speaker. Ahmed valve in patient with keratoplasty: recurrent extrusion despite everything. 10th Spanish Glaucoma Society Conference. Madrid Arrondo E. (2015) Speaker. Course on the management of complex clinical cases of glaucoma. Santa Creu i Sant Pau Hospital. Barcelona Arrondo E. (2014). Speaker. Clinical & Surgical Glaucoma Management of BKPRO Type I. 5th EUCORNEA Congress. London Arrondo E. (2014). Speaker. Non-penetrating filtration surgery: when and how? Paediatric Glaucoma Course at Vall d'hebron. Barcelona Arrondo E. (2014). 1 Moderator. Keratoplasty and Glaucoma Symposium 2. Speaker. OHT mechanisms in the patient undergoing keratoplasty. 29th Confer- ence of the Spanish Society of Implanto-Refractive Eye Surgery. Alicante. Arrondo E. (2014). 1. Speaker. Glaucoma worsens: multi-tube surgery. What do we do then? 2. Video Symposium. Ahmed valve implants in lower nasal quadrant. 9th Conference of the Spanish Glaucoma Society. Murcia.

Arrondo E. (2014). Speaker. Conference on surface and glaucoma. Madrid Arrondo E. (2014). 1. Organising committee 2. Mod- erator. A. Session: Preventing healing. Prevention and treatment of filtration surgery failure... B. Session: At- titude towards a normal-tension glaucoma 3. Speaker. A.Deep sclerectomy B. Mechanisms of glaucoma as- sociated with phakic lenses: diagnosis and treatment C. Glaucoma associated with corneal grafts. Trends in Glaucoma. Barcelona. Arrondo E. (2014) Speaker. Course on managing clinical cases of glaucoma at the Hospital de la Santa Creu i Sant Pau. Barcelona. Arrondo E. (2013) La Toja Glaucoma Workshop. La Toja. Arrondo E. (2013) Speaker. Pros and Cons: 2. I prefer the Ahmed valve. Annual Conference of the Spanish Glaucoma Society. Cordoba. Arrondo E. (2013) Speaker. Roundtable 2: New im- plants in glaucoma surgery. Cons. 89th Conference of the Spanish Ophthalmology Society. Tenerife Recent publications Mazzarella S, Mateo C., Freixes S., Burés-Jelstrup A., Ríos J, Navarro R, García-Arumí J, Corcóstegui B, Arrondo E. Effect of intravitreal Injection of Dexamethasone 0,7 mg (Ozurdex ) on Intraocular Pressure in Patients with Macular Edema. Ophthalmic Res 2015; 54 (3): 143-9. Rebolleda G., Díez-Álvarez L., Arrondo E., Ley L., Martínez-San Millán J., Muñoz- Negrete FJ. Neurological Hemifield Test in Binasal Defects. Invest. Ophthalmol. Vis. Sci.. 2015; 56(4):2568-2569. Doi:10.11677iovs.15-16656 Arrondo E. (2015).Técnica quirúrgica del implante de Cypas. Annals d Oftalmologia 5/2015 Arrondo E. (2015) Glaucoma and KPro. Prevalence, severity and impact on vision underscore need for frequent evaluation and aggressive management. Eurotimes, 20 (2), 15

Medel R, Hristodulopulos V, Mazzarella S, Arrondo E. Upper eyelid tarsoconjunctival flap for the treatment of Ahmed valve plate exposure. J Glaucoma. 2014 Oct-Nov; 23(8):579-81. doi: 10.1097/IJG.0000000000000079. Rusiñol E, Arrondo A, Gris O, Mateo C, Freixes S. Utilidad del GPA-OCT en el seguimiento del glaucoma. Revista Española de Glaucoma. Junio 2012. Bartra J, Arrondo E. Actualización en alergia ocular. Tomos 1,2, y 3. Editorial Glosa. 1a edición 1993. Salvador A, Alarcón S, Arrondo E, Casado J, Mousaci K, Arcediano MA, Torras J, Sánchez-Dalmau B, Pascual L. Atlas macroscópico de patología ocular. Editorial Glosa. 1a edición 2005.